[1]
R. P. Meng, “Clinical Efficacy of Early and Late Vedolizumab or Infliximab Interventions in Moderate Ulcerative Colitis: A Multicenter, Retrospective Cohort Study”, Gastroenterol Res, vol. 19, no. 1, pp. 35–42, Jan. 2026, doi: 10.14740/gr2092.